Lv1
50 积分 2021-04-26 加入
IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II
1个月前
已完结
RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy
8个月前
已完结
Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process
8个月前
已完结
RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy
8个月前
已完结
Role of APR3 in cancer: apoptosis, autophagy, oxidative stress, and cancer therapy
8个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1年前
已完结
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
1年前
已完结
Expanding access to CAR T cell therapies through local manufacturing
1年前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
1年前
已完结
皖公网安备34019202002308
